Phase III Clinical Trial Success: Oxford COVID-19 Vaccine Is Safe and Protects Against Disease
First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease,…